Antihypertensive Medication Classes: Mechanisms, Examples, Pregnancy Safety, and Contraindications
1. Thiazide and Thiazide-Like Diuretics
Mechanism of Action:
- Promote sodium and water excretion by inhibiting sodium-chloride cotransporter in the distal convoluted tubule, leading to decreased intravascular volume 1
- Act as indirect vasodilators by depleting salt and water within the intramural portion of arterioles, diminishing responsiveness to catecholamines and angiotensin II 2
Examples:
Pregnancy Safety:
- NOT recommended during pregnancy 1, 3
- May reduce normal plasma volume expansion and compromise uteroplacental perfusion 3
- Chronic use associated with restricted maternal plasma volume and reduced uteroplacental perfusion 1
- May increase risk of pre-eclampsia 3
Contraindications:
2. ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
Mechanism of Action:
- Inhibit conversion of angiotensin I to angiotensin II, decreasing vasoconstriction and aldosterone production 2
- Reduce both preload and afterload through vasodilation 4
Examples:
Pregnancy Safety:
- CONTRAINDICATED during pregnancy 1, 5
- May cause fetal renal dysplasia, oligohydramnios, intrauterine growth restriction, and fetal death 1
- Women who become pregnant must be transitioned immediately to safe alternatives 1
Contraindications:
3. Angiotensin II Receptor Blockers (ARBs)
Mechanism of Action:
- Block angiotensin II at AT1 receptors, preventing vasoconstriction and aldosterone secretion 6
- Provide similar hemodynamic effects to ACE inhibitors without affecting bradykinin metabolism 6
Examples:
Pregnancy Safety:
- CONTRAINDICATED during pregnancy 1, 5
- Cause severe fetotoxicity including renal dysplasia and fetal death 8
- Must be discontinued immediately upon pregnancy recognition 1
Contraindications:
- Pregnancy (all trimesters) 1, 6
- Concomitant use with ACE inhibitors or renin inhibitors (increases cardiovascular and renal risk) 1
4. Calcium Channel Blockers (CCBs)
Mechanism of Action:
- Block L-type calcium channels in vascular smooth muscle and cardiac tissue, causing vasodilation and reduced peripheral resistance 9
- Dihydropyridines (e.g., nifedipine) are more selective for vascular smooth muscle 10
Examples:
Pregnancy Safety:
- SAFE for use during pregnancy 1, 8
- Extended-release nifedipine is a first-line option for hypertension in pregnancy 8
- Caution: Avoid concurrent use with magnesium sulfate due to risk of precipitous blood pressure drop 5
Contraindications:
- Severe aortic stenosis (for dihydropyridines) 1
- Acute myocardial infarction with pulmonary congestion 1
5. Beta-Blockers
Mechanism of Action:
- Block beta-adrenergic receptors, decreasing cardiac output, heart rate, and renin release 2
- Inhibit prejunctional release of norepinephrine and may have central nervous system effects 2
Examples:
Pregnancy Safety:
- Labetalol is SAFE and preferred during pregnancy 1, 5, 8
- Atenolol should be avoided due to association with intrauterine growth restriction 1
- Labetalol has efficacy comparable to methyldopa with fewer side effects 5
Contraindications:
6. Aldosterone Antagonists (Potassium-Sparing Diuretics)
Mechanism of Action:
- Block aldosterone receptors in the distal tubule and collecting duct, promoting sodium excretion while retaining potassium 1
- Reduce sodium reabsorption without causing hypokalemia 1
Examples:
Pregnancy Safety:
- Limited safety data; generally avoided during pregnancy 1
- Not recommended as first-line agents in pregnancy due to insufficient evidence 3
Contraindications:
7. Alpha-1 Adrenergic Blockers
Mechanism of Action:
- Block alpha-1 receptors on vascular smooth muscle, causing vasodilation and reduced peripheral resistance 2
- Decrease blood pressure without reflex tachycardia 9
Examples:
Pregnancy Safety:
Contraindications:
8. Centrally Acting Agents
Mechanism of Action:
- Act on central alpha-2 receptors in the brainstem, decreasing sympathetic outflow from the vasomotor center 2
- Reduce peripheral vascular resistance and heart rate 2
Examples:
Pregnancy Safety:
- SAFE and PREFERRED during pregnancy 1, 5, 8
- Methyldopa has the longest safety record and is considered first-line 5
- Clonidine is also safe and effective 1, 8
Contraindications:
Key Clinical Considerations
Primary Agents for General Hypertension: The ACC/AHA guidelines identify thiazide diuretics, ACE inhibitors, ARBs, and CCBs as primary agents with proven reduction in clinical events 1. Beta-blockers lack adequate evidence for initial use in uncomplicated hypertension 1.
Pregnancy-Safe Algorithm: For hypertensive pregnant women, the treatment hierarchy is: 1) Methyldopa or labetalol as first-line; 2) Nifedipine (extended-release) as second-line; 3) Avoid ACE inhibitors, ARBs, and diuretics unless specific indications exist 8, 5, 1.
Critical Pitfall: Simultaneous use of ACE inhibitors with ARBs or renin inhibitors is potentially harmful and increases cardiovascular and renal risk 1. This combination should never be used 1.